NCT00007865View on ClinicalTrials.gov

Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 1, 2000

Primary Completion Date

March 1, 2004

Study Completion Date

April 22, 2008

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

DRUG

carboplatin

DRUG

etoposide

DRUG

ifosfamide

Trial Locations (1)

68198-7680

University of Nebraska Medical Center, Eppley Cancer Center, Omaha

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Nebraska

OTHER

NCT00007865 - Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter